ElevateBio, a Massachusetts-based gene therapy startup, announced $401 million in Series D funding.
Venture
![Illustration of man and robot looking at each other. [Dom Guzman]](https://news.crunchbase.com/wp-content/uploads/AI_robotics_Facing-470x352.jpg)
Later-stage investment in AI is hopping with ChatGPT rival Anthropic's Series C and software development platform Builder.ai's Series D.
Some of those sky-high unicorn valuations now seem as real as unicorns.
Following his layoff, tech worker Anmol Sahai took the chance to found a workflow software startup for in-house legal teams.
We used Crunchbase data to look at how some venture-backed AI companies that went public on U.S. exchanges in the past three years are faring.
After several weeks of just having one or two rounds of nine figures, this week saw an explosion. Eight rounds hit $100 million or more as big rounds...
The e-commerce unicorn quickly won the hearts of American consumers during the pandemic, but Shein now faces numerous obstacles.
BoltRock Holdings and Centaurus Capital led the Series D round for Boston-based Gradiant, which is now valued at $1 billion.
Managing communication with investors is crucial for the success of a startup. Ripple Ventures' Matt Cohen shares a few key ways that startups can...
Unlike many industries, semiconductors did not see a huge falloff last year in funding from 2021. Will AI play a role in the next chapter for the...
The New York-based crossover investment giant has hired an adviser to help it sell off some stakes in startups.
![Illustration of a guy watering plants with a blocked hose - Global [Dom Guzman]](https://news.crunchbase.com/wp-content/uploads/quarterly-global-3-300x168.jpg)
67.1K Followers